Skip to main content
. 2004 Apr 5;142(1):125–135. doi: 10.1038/sj.bjp.0705747

Figure 4.

Figure 4

Relaxations of PCMAs, preconstricted with U46619, to DEA-NONOate in the absence (control) or presence of one or more of the following inhibitors: 10 μM ODQ, 200 μM hydroxocobalamin (HC), 100 nM charybdotoxin (char) or 100 nM apamin (apa). Data (mean±s.e.mean; n=4) are expressed as a percentage of the contraction induced by U46619.